LAS VEGAS, Aug. 28, 2009 (GLOBE NEWSWIRE) -- Sometimes eight billion units isn't enough. With an international market opportunity in the 30 billion unit range, E-18 Corp. (OTCBB:ETEN) filed for international patent protection on its better mousetrap device, a revolutionary self-sheathing medical safety syringe technology. This filing was made through the international Patent Cooperation Treaty and allows the company to enjoy patent-pending status in 140 countries, plus Taiwan, for 18 months. This window of protection also allows E-18 Corp's Protectus Medical Devices to make formal patent applications in any or all of these countries.
A company profile of E-18 Corp and of interest to investors of medical device leaders Medtronic Inc (NYSE:MDT), Varian Medical Systems (NYSE:VAR), NxStage Medical Inc. (Nasdaq:NXTM), and Intuitive Surgical Inc. (Nasdaq:ISRG) has been made available at www.SmallCapSentinel.com/ETEN
For Protectus, the scope of the patent protection opens doors into these international markets and preserves the opportunity, making the filing a milestone event for the company. Dr. John Salstrom, President and CEO of Protectus Medical Devices, believes that the patent protection increases the market opportunity for the company from eight billion syringes sold in the United States annually, to 30 billion syringes sold worldwide.
Please register to receive information on emerging public companies at: www.SmallCapSentinel.com/register
Watch a video demo of the product here: http://www.protectusmedical.com/flash_syringe_demo.html
E-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices, develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim.
Join the discussion on all aspects of the stock market at www.FiSpace.net, a social networking and blog site for investors.
Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. Small Cap Sentinel is property of Integrity Media Inc. (IMI). IMI provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies haven't always approved statements made in this report. This report is neither a solicitation to buy nor offer to sell securities but is for information purposes only and shouldn't be used as the basis for any investment decision. IMI is not an investment advisor, analyst or licensed broker dealer and this report isn't investment advice. IMI has been paid $5,000 for this report and other advertising services by Trilogy Capital Partners, a financial p.r. consultant to ETEN. Paid reports constitute a conflict of interest as to IMI's ability to remain objective in communication regarding subject companies.